SeqLL, LLC provides quantitative RNA and specialty DNA sequencing services utilizing true single molecule sequencing technology. With strong ties to Helios, personnel, IP and system after that firm went bankrupt in 2012, Swqll offers a range of quantitative RNA sequencing services for global gene expression studies, rare point mutation detection, True Single Molecule Sequencing (tSMS) biomarker discovery, and other applications. Its services include DRS genetic testing and mapping services; tSMS services to analyze damaged or fragmented nucleic acids from formalin fixed paraffin embedded samples and other difficult sources; micro RNA sequencing; and custom sequencing, mapping, and testing. The firm also provides specialty DNA sequencing for applications, such as sequencing DNA from ancient, damaged, or degraded samples; performing forensic DNA analysis; characterizing microbial diversity for infectious disease and microbiome; sequencing cell free DNA (CFDNA) from liquid biopsy samples; identifying point mutations and fusion events in tumor DNA samples; capturing selected sequences or gene panels directly on the flow cell surface; performing single molecule chip-SEQ.
